| Population wide sarcopenia and sarcopenic obesity analysis |
Andrew Green |
The University of Manchester |
NLST |
Apr 17, 2019 |
NLST-497 |
| Post-diagnosis exercise and mortality risk in cancer survivors |
Jessica Gorzelitz |
University of Iowa |
PLCO |
Sep 6, 2022 |
PLCO-1032 |
| Practice patterns for FDG PET-CT and FDG PET Imaging During Lung Cancer Screening Evaluation |
Viswam Nair |
Leland Stanford Junior University |
NLST |
Apr 14, 2014 |
NLST-68 |
| Pre- and Post-diagnostic NSAID Use and Prostate Cancer Mortality among Prostate Cancer Cases |
Michael Cook |
HREB/DCEG/NCI |
PLCO |
Mar 13, 2015 |
PLCO-136 |
| Precise ENB navigation to lung lesions for diagnosis and therapy through modelling of lung deformations |
Nicolas Merlet |
Medtronic-Covidien |
NLST |
Mar 4, 2015 |
NLST-124 |
| Precision medicine via survival analysis |
Yan Li |
University of Michigan |
NLST |
Jul 6, 2017 |
NLST-326 |
| Precision nutrition approaches to prostate cancer prevention: role of insulinemic dietary patterns on lethality |
Fred Tabung |
The Ohio State University Comprehensive Cancer Center |
PLCO |
Apr 16, 2024 |
2023-0064 |
| Pre-diagnostic aspirin use, lymph node involvement and mortality in women with stage I-III breast cancer. |
Marie Bradley |
NCI, DCCPS, CTEB |
PLCO |
Feb 3, 2014 |
PLCO-62 |
| Pre-diagnostic body mass index in relation to hormone receptor positive versus hormone receptor negative breast cancer incidence and mortality |
Omar Abdel-Rahman |
Avicenna Oncology center |
PLCO |
Dec 28, 2018 |
PLCO-432 |
| Pre-diagnostic obesity and pancreatic cancer survival |
Adetunji Toriola |
Washington University School of Medicine |
PLCO |
May 22, 2013 |
PLCO-34 |
| Pre-diagnostic obesity, smoking and lymph node involvement at breast cancer diagnosis. |
Ian Barron |
Johns Hopkins |
PLCO |
Sep 9, 2014 |
PLCO-99 |
| Pre-diagnostic serum metabolomic profiling and risk of prostate cancer |
Demetrius Albanes |
NCI |
PLCO |
Mar 7, 2014 |
2014-0030 |
| Predict disease-specific mortality for lung cancer in NLST sub-groups |
ping hu |
NCI |
NLST |
Dec 14, 2012 |
NLST-6 |
| PREDICTED MORTALITY AS A SURROGATE ENDPOINT IN THE PLCO TRIAL |
Matejka Rebolj |
Queen Mary University of London |
PLCO |
Oct 11, 2022 |
PLCO-1066 |
| Predict false positive rate for lung cancer screening tests in the NLST data |
ping hu |
NCI |
NLST |
Jan 9, 2014 |
NLST-45 |
| Predict histological grade by CT image auto-reviewing |
Edwin Wang |
University of Calgary |
NLST |
Aug 16, 2017 |
NLST-340 |
| Predicting 5-year risk of lung cancer using LDCT images |
Shu Jiang |
Washington University School of Medicine |
NLST |
Jul 15, 2024 |
NLST-1293 |
| Predicting Cancer diagnosis based on preliminary screenings |
Jonathan Mendoza |
Independent |
PLCO |
Oct 24, 2019 |
PLCO-532 |
| Predicting cancer-specific mortality using histopathology slides |
Shu Jiang |
Washington University in St. Louis |
PLCO |
Apr 18, 2024 |
PLCOI-1532 |
| Predicting Endometriosis Using Machine Learning |
Jessica Duffield |
University of the West of England |
PLCO |
Mar 2, 2022 |
PLCO-928 |
